Regulus Therapeutics Inc. (RGLS) Operating Income (Loss) USD 2011 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Regulus Therapeutics Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2011 to 2024.
  • Regulus Therapeutics Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$8.83 M, a 19.8% decline year-over-year.
  • Regulus Therapeutics Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$32.6 M, a 12.1% decline year-over-year.
  • Regulus Therapeutics Inc. annual Operating Income (Loss) for 2023 was -$31.1 M, a 10.2% decline from 2022.
  • Regulus Therapeutics Inc. annual Operating Income (Loss) for 2022 was -$28.2 M, a 1.52% decline from 2021.
  • Regulus Therapeutics Inc. annual Operating Income (Loss) for 2021 was -$27.8 M, a 96.5% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$32.6 M -$8.83 M -$1.46 M -19.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$31.1 M -$8.3 M -$1.37 M -19.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 -$29.7 M -$8.13 M -$562 K -7.43% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$29.2 M -$7.32 M -$140 K -1.95% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-08
Q1 2023 -$29 M -$7.37 M -$800 K -12.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$28.2 M -$6.93 M +$29 K +0.42% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 -$28.3 M -$7.56 M +$856 K +10.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$29.1 M -$7.18 M -$537 K -8.09% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$28.6 M -$6.57 M -$771 K -13.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 -$27.8 M -$6.96 M -$5.93 M -576% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-23
Q3 2021 -$21.9 M -$8.42 M -$7.32 M -669% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$14.6 M -$6.64 M -$142 K -2.19% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$14.4 M -$5.8 M -$263 K -4.75% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 -$14.2 M -$1.03 M +$3.41 M +76.8% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-11
Q3 2020 -$17.6 M -$1.1 M +$3.9 M +78.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 -$21.5 M -$6.5 M -$1.83 M -39.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 -$19.6 M -$5.54 M -$2.8 M -102% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 -$16.8 M -$4.44 M +$3.55 M +44.4% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-09
Q3 2019 -$20.4 M -$4.99 M +$4.86 M +49.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$25.2 M -$4.67 M +$8.68 M +65% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-13
Q1 2019 -$33.9 M -$2.74 M +$12.8 M +82.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-14
Q4 2018 -$46.8 M -$7.98 M +$5.72 M +41.8% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-12
Q3 2018 -$52.5 M -$9.85 M +$5.56 M +36.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$58 M -$13.3 M +$7.97 M +37.4% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 -$66 M -$15.6 M +$4.11 M +20.9% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$70.1 M -$13.7 M +$6.04 M +30.6% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-18
Q3 2017 -$76.2 M -$15.4 M +$3.78 M +19.7% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 -$79.9 M -$21.3 M -$129 K -0.61% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$79.8 M -$19.7 M +$1.69 M +7.88% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$81.5 M -$19.7 M -$12.4 M -168% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-18
Q3 2016 -$69.1 M -$19.2 M -$5.85 M -43.8% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 -$63.3 M -$21.2 M -$7 K -0.03% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 -$63.3 M -$21.4 M -$8.51 M -66.1% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-05
Q4 2015 -$54.8 M -$7.36 M +$2.17 M +22.8% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-08
Q3 2015 -$56.9 M -$13.3 M -$1.69 M -14.5% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-02
Q2 2015 -$55.2 M -$21.2 M -$8.17 M -62.8% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-03
Q1 2015 -$47.1 M -$12.9 M -$2.17 M -20.2% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-03
Q4 2014 -$44.9 M -$9.53 M -$4.87 M -105% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-03
Q3 2014 -$40 M -$11.7 M -$8.75 M -301% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 -$31.3 M -$13 M -$8.33 M -178% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-05
Q1 2014 -$23 M -$10.7 M -$5.16 M -92.9% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 -$17.8 M -$4.66 M -$357 K -8.3% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-23
Q3 2013 -$17.4 M -$2.91 M +$627 K +17.8% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-06
Q2 2013 -$18.1 M -$4.69 M -$2.13 M -83.2% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 -$15.9 M -$5.55 M -$3.37 M -155% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-09
Q4 2012 -$12.6 M -$4.3 M Oct 1, 2012 Dec 31, 2012 10-K 2015-02-19
Q3 2012 -$3.53 M -$2.56 M -263% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 -$2.56 M Apr 1, 2012 Jun 30, 2012 10-Q/A 2013-08-16
Q1 2012 -$2.18 M Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q3 2011 -$973 K Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.